Tong Yi Tang Pharmaceutical Co.,Ltd.,Wu Jieping Foundation Clinical Research Special Project(320.6750.2021-19-2);Fujian Province Natural Science Foundation Project(2023J011619);Xiamen Science and Technology Program(No.3502Z20227342)。
Objective:This study aimed to assess the effects of the Jinfeng pill on ovarian volume and endocrine function in rats with poor ovarian response and to elucidate the gene expression changes that contribute to the Jinf...
supported by the National Natural Science Foundation of China,Nos.81801169 (to LXX),82071404 (to HC),81870952 (to HMW)。
Promotion of new blood vessel formation is a new strategy for treating ischemic stroke.Non-coding miRNAs have been recently considered potential therapeutic targets for ischemic stroke.miR-181b has been shown to promo...
PEP06 is a novel endostatin-Arg-Gly-Asp-Arg-Gly-Asp(RGDRGD)30-amino-acid polypeptide featuring a terminally fused RGDRGD hexapeptide at the N terminus.The active endostatin fragment of PEP06 directly targets tumor cel...
Objective: malignant tumor is recognized as one of the most terrible and difficult diseases to treat in the world medical system. At present, the common methods to treat malignant tumors are radiotherapy, chemotherapy...
Supported by the Natural Science Foundation of China(No.81602531).
Objective The aim of our study was to detect the expression of angiogenesis inhibitory proteins and angiogenesis promotive proteins in the postoperative tumor tissue of non-small cell lung cancer(NSCLC)patients.We als...